| 注册
首页|期刊导航|中医杂志(英文版)|Efficacy of Jiedu formula(解毒方)as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery:a propensity score matching study

Efficacy of Jiedu formula(解毒方)as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery:a propensity score matching study

FENG Qiuting HU Jiajia YU Song ZHU Huirong CHENG Simo ZHAI Xiaofeng

中医杂志(英文版)2025,Vol.45Issue(2):443-449,7.
中医杂志(英文版)2025,Vol.45Issue(2):443-449,7.DOI:10.19852/j.cnki.jtcm.2025.02.019

Efficacy of Jiedu formula(解毒方)as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery:a propensity score matching study

Efficacy of Jiedu formula(解毒方)as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery:a propensity score matching study

FENG Qiuting 1HU Jiajia 2YU Song 2ZHU Huirong 3CHENG Simo 2ZHAI Xiaofeng2

作者信息

  • 1. School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China||Oncology department,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
  • 2. School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China
  • 3. Department of Oncology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
  • 折叠

摘要

关键词

carcinoma,hepatocellular/chemotherapy,adjuvant/propensity score/liver resection/Jiedu formula

Key words

carcinoma,hepatocellular/chemotherapy,adjuvant/propensity score/liver resection/Jiedu formula

引用本文复制引用

FENG Qiuting,HU Jiajia,YU Song,ZHU Huirong,CHENG Simo,ZHAI Xiaofeng..Efficacy of Jiedu formula(解毒方)as adjuvant therapy for early recurrence of hepatocellular carcinoma after radical surgery:a propensity score matching study[J].中医杂志(英文版),2025,45(2):443-449,7.

基金项目

Supported by Natural Science Foundation-funded Project:Mechanism of Action of Detoxification Formula to Inhibit Hypoxia-Inducible Factor 1 Alpha-Exosomal MicroRNA-130b-3p-Sterile Alpha Motif Domain-Containing Protein 90-mediated Macrophage M2-type Polarisation to Improve the Immunosuppressive Microenvironment in Hepatocellular Carcinoma(No.82374540),and Medical Innovation Research Project of Shanghai Science and Technology Commission:a Multicenter Pro-spective Randomized Controlled Study of"Arsenic Target"Combination Therapy for Unresectable Hepatocellular Carcinoma(No.22Y11921200) (No.82374540)

中医杂志(英文版)

0255-2922

访问量0
|
下载量0
段落导航相关论文